First test of new allergy shot begins in healthy volunteers
Knowledge-focused
Recruiting now
This is the first study in humans to test the safety of a new drug called Exl-111, which is being developed for allergic diseases. The trial will enroll 70 healthy adults to receive either the drug or a placebo injection. The main goal is to check for side effects and see how the…
Phase: PHASE1 • Sponsor: Excellergy Inc. • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC